Secondly, RA patients with lower sST2 levels at baseline are those who more likely achieved remission following 12 months of treatment with disease modifying anti-rheumatic drugs (DMARDs) and anti-TNF-α agents [30]. Here, TNF is linked to rheumatoid arthritis.